EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

β-Lactamase cleavable antimicrobial peptide–drug conjugates

Tomas Deingruber iD, Josephine S Gaynord iD, Bee Ha Gan, Kristina A Kostadinova iD, Thomas J O'Brien iD, Yaw Sing Tan, Jeremy S Parker iD, Thomas A Hunt iD, Jason S Carroll, Martin Welch, David R Spring iD

Chemical Science · 2025 · 16 (41) · 19288-19295

DOI: 10.1039/d5sc06369h ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Science, 2025. Verfasst von Tomas Deingruber und 10 weiteren Autor:innen. Beteiligte Einrichtung: Yusuf Hamied Department of Chemistry, University of Cambridge Lensfield Road Cambridge UK spring@ch.cam.ac.uk. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Agency for Science, Technology and Research, Cystic Fibrosis Trust, Leverhulme Trust.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

From a series of peptides, the most promising was developed into a stapled conjugate, with a ciprofloxacin prodrug attached to the staple via a cephalosporin linker. Factors influencing antibacterial activity and drug release were investigated.

Autor:innen und Institutionen

  • Yusuf Hamied Department of Chemistry, University of Cambridge Lensfield Road Cambridge UK spring@ch.cam.ac.uk.
  • Department of Biochemistry, University of Cambridge Hopkins Building Tennis Court Road Cambridge UK mw240@cam.ac.uk.
  • Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR) Singapore.
  • Early Chemical Development, Pharmaceutical Development, R&D, AstraZeneca Macclesfield UK.
  • Oncology R&D, AstraZeneca Cambridge UK.
  • Cancer Research UK Cambridge Institute Robinson Way Cambridge CB2 ORE UK.

ORCID-Profile: Tomas Deingruber, Josephine S Gaynord, Kristina A Kostadinova, Thomas J O'Brien, Jeremy S Parker, Thomas A Hunt, David R Spring

Förderung

  • Agency for Science, Technology and Research
  • Cystic Fibrosis Trust
  • Leverhulme Trust
  • UK Research and Innovation
  • EPSRC Centre for Doctoral Training in Medical Imaging
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Deingruber, T., Gaynord, J. S., Gan, B. H., Kostadinova, K. A., O'Brien, T. J., Tan, Y. S., Parker, J. S., Hunt, T. A., Carroll, J. S., Welch, M., & Spring, D. R. (2025). β-Lactamase cleavable antimicrobial peptide–drug conjugates. Chemical Science, 16(41), 19288-19295. https://doi.org/10.1039/d5sc06369h

Vancouver

Deingruber T, Gaynord JS, Gan BH, Kostadinova KA, O'Brien TJ, Tan YS, et al. β-Lactamase cleavable antimicrobial peptide–drug conjugates. Chemical Science. 2025;16(41):19288-19295. doi:10.1039/d5sc06369h

BibTeX
@article{Deingruber2025,
  author = {Deingruber, Tomas and Gaynord, Josephine S and Gan, Bee Ha and Kostadinova, Kristina A and O'Brien, Thomas J and Tan, Yaw Sing and Parker, Jeremy S and Hunt, Thomas A and Carroll, Jason S and Welch, Martin and Spring, David R},
  title = {β-Lactamase cleavable antimicrobial peptide–drug conjugates},
  journal = {Chemical Science},
  year = {2025},
  volume = {16},
  number = {41},
  pages = {19288--19295},
  doi = {10.1039/d5sc06369h}
}
Kostenlos starten →